Hims & Hers Health Inc (NYSE: HIMS) kicked off on Friday, up 5.72% from the previous trading day, before settling in for the closing price of $32.87. Over the past 52 weeks, HIMS has traded in a range of $11.20-$72.98.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Consumer Defensive sector has jumped its sales by 62.28% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 12.77%. With a float of $182.04 million, this company’s outstanding shares have now reached $212.46 million.
In an organization with 1637 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 76.65%, operating margin of 4.24%, and the pretax margin is 4.86%.
Hims & Hers Health Inc (HIMS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Household & Personal Products Industry. The insider ownership of Hims & Hers Health Inc is 18.06%, while institutional ownership is 73.61%. The most recent insider transaction that took place on Mar 21 ’25, was worth 2,413,110. Before that another transaction happened on Mar 18 ’25, when Company’s Chief Medical Officer sold 23,287 for $34.31, making the entire transaction worth $798,977. This insider now owns 209,661 shares in total.
Hims & Hers Health Inc (HIMS) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.77% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.05% during the next five years compared to 17.22% growth over the previous five years of trading.
Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators
Take a look at Hims & Hers Health Inc’s (HIMS) current performance indicators. Last quarter, stock had a quick ratio of 1.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.23. Likewise, its price to free cash flow for the trailing twelve months is 38.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.53, a number that is poised to hit 0.11 in the next quarter and is forecasted to reach 0.86 in one year’s time.
Technical Analysis of Hims & Hers Health Inc (HIMS)
Let’s dig in a bit further. During the last 5-days, its volume was 23.34 million. That was better than the volume of 22.73 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 42.27%. Additionally, its Average True Range was 4.54.
During the past 100 days, Hims & Hers Health Inc’s (HIMS) raw stochastic average was set at 30.05%, which indicates a significant decrease from 33.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 104.73% in the past 14 days, which was lower than the 131.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $38.48, while its 200-day Moving Average is $25.81. However, in the short run, Hims & Hers Health Inc’s stock first resistance to watch stands at $36.01. Second resistance stands at $37.26. The third major resistance level sits at $39.33. If the price goes on to break the first support level at $32.69, it is likely to go to the next support level at $30.62. Assuming the price breaks the second support level, the third support level stands at $29.37.
Hims & Hers Health Inc (NYSE: HIMS) Key Stats
The company with the Market Capitalisation of 7.72 billion has total of 222,166K Shares Outstanding. Its annual sales at the moment are 1,477 M in contrast with the sum of 126,040 K annual income. Company’s last quarter sales were recorded 481,140 K and last quarter income was 26,030 K.
